Endothelial-monocyte activating polypeptide II (EMAP II) is a tumor-derived pro-inflammatory cytokine that was initially identified in the supernatant of murine methylcholanthrene A-induced fibrosarcomas (Meth A) (Kao et al., 1994). This evidence concerns the gene AIMP1 and fibrosarcoma.